Neurovive and Isomerase enter agreement
June 17th, 2013 | by Anneli Hidalgo
Mitochondrial medicine company Neurovive Pharmaceutical recently announced the signing of a collaboration agreement with Isomerase Therapeutics. The agreement involves the
June 17th, 2013 | by Anneli Hidalgo
Mitochondrial medicine company Neurovive Pharmaceutical recently announced the signing of a collaboration agreement with Isomerase Therapeutics. The agreement involves the
June 17th, 2013 | by Anneli Hidalgo
On June 13, the US Supreme Court ruled unanimously that natural human genes cannot be patented. Human genes may not
June 11th, 2013 | by Anneli Hidalgo
On June 10, AstraZeneca announced the acquisition of California-based Pearl Therapeutics to strengthen the company’s respiratory portfolio. Pearl Therapeutics is
June 11th, 2013 | by Chris Tachibana
Breast cancer is the most intensively researched type of cancer, but recent studies have taught us even more, using new
June 11th, 2013 | by Anneli Hidalgo
Swedish Ortivus has been pointed out as a supplier of medical records in a large European procurement involving several ambulance
June 10th, 2013 | by Anneli Hidalgo
Recently, members of the European Parliament’s environment, health and food safety committee voted for greater transparency in the European Commission’s
June 10th, 2013 | by Anneli Hidalgo
Turku Science Park has signed a new agreement with Akron Development Corporation to promote Finnish and American biotech. The Memorandum
June 7th, 2013 | by Anneli Hidalgo
Enzymatica and the international pharmaceuticals company, Actavis, have signed a letter of intent on the sale of Enzymatica’s cold treatment
June 7th, 2013 | by Anneli Hidalgo
Investment company Allenex has agreed to sell its holding in Anamar AB to the company’s main owner Koncentra Holding. Allenex became
May 29th, 2013 | by Anneli Hidalgo
AstraZeneca has entered into a definitive agreement to acquire Omthera Pharmaeuticals for up to $443m. The specialty pharmaceutical company is
May 24th, 2013 | by Anneli Hidalgo
Nordic Life Science Review has talked to Peter Asplund at ASCRO who gave us some insight into the last months’
May 24th, 2013 | by Anneli Hidalgo
Novo A/S, the holding company of the Novo Group, has purchased all shares in pharmaceutical group Xellia Pharmaceuticals for approximately
May 22nd, 2013 | by Anneli Hidalgo
Swedish biotech company Affibody received this year’s SwedenBIO Award during SwedenBIO’s annual conference on May 21 in Stockholm. The jury’s
May 22nd, 2013 | by Anneli Hidalgo
Generic drug maker Actavis Inc recently announced the purchase of specialty pharmaceutical company Warner Chilcott Plc. Under the agreement, Actavis
May 20th, 2013 | by Malin Anderson
The Carlsbad, CA-based contract research organization (CRO) Synteract has acquired the international CRO Munich-based company Harrison Clinical Research. The company
May 20th, 2013 | by Malin Anderson
On April 26th TFS International (TFS) completed the acquisition of the New Jersey-based Oncology and Vaccine specialist Contract Research Organization
May 19th, 2013 | by Anneli Hidalgo
Over the last few years the field of gene therapy has been a domain of controversies and security issues. But
May 19th, 2013 | by Anders Hansen
Swedish Medtech Company Aerocrine was formed in 1997, based on research conducted at the Karolinska Institute investigating nitric oxide (NO)
May 17th, 2013 | by Anneli Hidalgo
Swedish biotech company Nanologica has been awarded with the title Nanotech Company of the year. Nanologica received the award during
May 16th, 2013 | by Anneli Hidalgo
Swedish RaySearch Laboratories has received clearance from the FDA for RayStation 3.5 meaning that the new features can be marketed in
Neurovive and Isomerase enter agreement
June 17th | by
Human genes can’t be patented
June 17th | by
AstraZeneca buys Pearl Therapeutics for $1.15 billion
June 11th | by
Breast cancer, revised
June 11th | by
Ortivus wins large procurement
June 11th | by
Companies : Trade Councils & Government Investment Agencies
Busine...0 comment(s)Subscribe to our magazine! : Sign up for a One Year subscription for 649 SEK / 71 EU...0 comment(s)Home :
...0 comment(s)The magazine : Nordic Life Science Review is well established as the l...0 comment(s)About us : THE NORDIC REGION possesses one of the strongest life s...0 comment(s)
